ArticleBlood2006

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

Raphaël F Rousseau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.